Your browser doesn't support javascript.
loading
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
Parsons, H A; Blewett, T; Chu, X; Sridhar, S; Santos, K; Xiong, K; Abramson, V G; Patel, A; Cheng, J; Brufsky, A; Rhoades, J; Force, J; Liu, R; Traina, T A; Carey, L A; Rimawi, M F; Miller, K D; Stearns, V; Specht, J; Falkson, C; Burstein, H J; Wolff, A C; Winer, E P; Tayob, N; Krop, I E; Makrigiorgos, G M; Golub, T R; Mayer, E L; Adalsteinsson, V A.
Afiliação
  • Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Heather_Parsons@dfci.harvard.edu.
  • Blewett T; Broad Institute of MIT and Harvard, Cambridge.
  • Chu X; Data Science, Dana-Farber Cancer Institute, Boston.
  • Sridhar S; Broad Institute of MIT and Harvard, Cambridge.
  • Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston.
  • Xiong K; Broad Institute of MIT and Harvard, Cambridge.
  • Abramson VG; Vanderbilt-Ingram Cancer Center, Nashville.
  • Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston.
  • Cheng J; Broad Institute of MIT and Harvard, Cambridge.
  • Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh.
  • Rhoades J; Broad Institute of MIT and Harvard, Cambridge.
  • Force J; Duke Cancer Center, Durham.
  • Liu R; Broad Institute of MIT and Harvard, Cambridge.
  • Traina TA; Memorial Sloan Kettering Cancer Center, New York.
  • Carey LA; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill.
  • Rimawi MF; Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston.
  • Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis.
  • Stearns V; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.
  • Specht J; Seattle Cancer Care Alliance, Seattle.
  • Falkson C; The University of Alabama at Birmingham, Birmingham.
  • Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.
  • Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.
  • Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.
  • Tayob N; Data Science, Dana-Farber Cancer Institute, Boston.
  • Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.
  • Makrigiorgos GM; Radiation Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Golub TR; Broad Institute of MIT and Harvard, Cambridge.
  • Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Erica_Mayer@dfci.harvard.edu.
  • Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge. Electronic address: viktor@broadinstitute.org.
Ann Oncol ; 34(10): 899-906, 2023 10.
Article em En | MEDLINE | ID: mdl-37597579
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas / DNA Tumoral Circulante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas / DNA Tumoral Circulante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article